Evidence map›Paper›PMID 38935456›Full record

ArticleJournal of water and health2024

Carbapenem-resistant

Shabnam Khavandi, Nasrin Habibzadeh, Kamal Hasani, Mehran Sardari, Mohsen Arzanlou

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of water and health, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Shabnam KhavandiFood and Drug Laboratories Research Center (FDLRC), Iran Food and Drug Administration (IFDA), Ministry of Health and Medical Education (MOH), Tehran, Iran; Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran.
Nasrin HabibzadehClinical Microbiology Laboratory, Imam Hospital, Ardabil University of Medical Sciences, Ardabil, Iran.
Kamal HasaniDepartment of Environmental Health Engineering, School of Public Health, Ardabil University of Medical Sciences, Ardabil, Iran.
Mehran SardariClinical Microbiology Laboratory, Imam Hospital, Ardabil University of Medical Sciences, Ardabil, Iran.
Mohsen ArzanlouFood and Drug Laboratories Research Center (FDLRC), Iran Food and Drug Administration (IFDA), Ministry of Health and Medical Education (MOH), Tehran, Iran; Department of Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, Iran; Zoonoses Research Center, Ardabil University of Medical Sciences, Ardabil, Iran E-mail: m.arzanlou@arums.ac.ir; arzanlo53@gmail.com.ORCID https://orcid.org/0000-0002-4233-9497

Funding

Iran Food and Drug Administration 10401
6 · The paper itself

Abstract

The carbapenem-resistant

Indexed as

CarbapenemsWastewaterAnimalsAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasesCarbapenem-Resistant EnterobacteriaceaeEnterobacteriaceaeHumansIranAnti-Bacterial AgentsBacterial Proteinsbeta-LactamasescarbapenemaseCarbapenemsWastewatercarbapenemasecarbapenem-resistanthumanslivestockpoultrywastewater

Identifiers

PMID38935456

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.